Olink Launches PLA-Based Plasma Protein Biomarker-Discovery Service

The service, which features a panel of 74 potential cancer protein biomarkers, uses the company's real-time PCR-based proximity ligation assay-based immunoassay platform to detect markers in plasma volumes as small as 2 microliters.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.